News

Preprint of Data from 1st 100 Participants in IRB-waived Research Study of Tollovid + Long COVID

Preprint of Data from 1st 100 Participants in I...

New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its...

Preprint of Data from 1st 100 Participants in I...

New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its...

Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study

Todos Medical Completes Trial Design for Tollov...

3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens Finalizing contracts with two Long COVID clinics to recruit patients Institutional Review Board (IRB) protocol submission imminent New York,...

Todos Medical Completes Trial Design for Tollov...

3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens Finalizing contracts with two Long COVID clinics to recruit patients Institutional Review Board (IRB) protocol submission imminent New York,...

Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics

Todos Medical Announces First Long COVID Clinic...

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug....

Todos Medical Announces First Long COVID Clinic...

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug....

Todos Medical & The Alchemist’s Kitchen to Host “Long COVID: An Integrated Approach” Event Benefitting Survivor Corps

Todos Medical & The Alchemist’s Kitchen to Host...

New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with...

Todos Medical & The Alchemist’s Kitchen to Host...

New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with...

IRB-Waived Tollovid® Research Data in Acute & Long COVID

IRB-Waived Tollovid® Research Data in Acute & L...

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced preliminary data from its majority-owned joint venture 3CL Pharma Ltd.’s ongoing IRB-waived sponsored market research...

IRB-Waived Tollovid® Research Data in Acute & L...

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced preliminary data from its majority-owned joint venture 3CL Pharma Ltd.’s ongoing IRB-waived sponsored market research...

Protect Your House: Tollovid® is Informed Sport Certified

Protect Your House: Tollovid® is Informed Sport...

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport certification for Tollovid®,...

Protect Your House: Tollovid® is Informed Sport...

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport certification for Tollovid®,...